Global registry for people with DRPLA
Part of Brain & nervous system clinical trials.
This study is a global patient registry that collects information from people with DRPLA to better understand the condition over time. It may help researchers learn what to expect and how to support future treatments, and participation mainly involves giving consent and sharing your history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or a legal representative) can sign the informed consent form.
- You have a self-reported diagnosis of DRPLA (Dravet-related?—note: exactly DRPLA)
- If you are under the age of consent (often age 12+), you can also be asked for assent along with a parent/guardian consent.
- If you cannot consent due to cognitive limitations, a legally authorized representative must provide consent and your assent is sought when possible.
- You should not have an ataxia (coordination/balance problem) diagnosis other than DRPLA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects medical and genetic information from people with rhizomelic chondrodysplasia punctata (RCDP) or closely related conditions. It helps researchers better understand the condition and plan future studies that could lead to better care.
This study collects health information from children and young adults with a rare genetic condition called rhizomelic chondrodysplasia punctata (RCDP) to learn more about how the condition affects people over time. By participating, you can help doctors better understand the condition and improve future care.
This registry asks people with Parkinson’s disease to join a research program at the University of Delaware. Being in the registry may help you get invited to investigator-led studies that could improve understanding or treatment of Parkinson’s.
This study builds a national registry to better understand adrenoleukodystrophy (ALD) in patients and families. You may help researchers learn how ALD affects people over time and improve future care.
This study is a registry that collects information from people with Parkinson’s disease to better understand the condition. You may help researchers learn about patterns of symptoms and care over time.
This trial is a patient registry that collects information from people who have—or might have—autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand the condition and improve future studies.
Hear when a new DRPLA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.